Retraction: Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis
Retraction to: Transl Androl Urol 2020;9:1670-7.
The article “Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis” (doi: 10.21037/tau-20-970) (1) published in Vol 9, No 4 (August 2020) issue has been retracted since the ethical approval number (SZFYIEC-PJ-2019-21) in the article was incorrect, which was related to lung cancer research rather than renal cell carcinoma. All authors agree with the retraction of the paper.
Footnote
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (http://dx.doi.org/10.21037/tau-2023-04/coif). The authors have no conflicts of interest to declare.
Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
References
- Shi L, Lv R, Li C, et al. Expression of vascular endothelial growth factor C in renal cell carcinoma and its correlation with pathological parameters and prognosis. Transl Androl Urol 2020;9:1670-7. [Crossref] [PubMed]
